• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tharimmune, Inc. - Common Stock (NQ: THAR )

2.260 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Tharimmune, Inc. - Common Stock

< Previous 1 2 3 Next >
10 Health Care Stocks Moving In Monday's Pre-Market Session
November 04, 2024
Via Benzinga
Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast
October 30, 2024
Via Benzinga
Exposures Fossil Fuels
S&P 500 Edges Lower; US Crude Oil Inventories Fall
October 30, 2024
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
What's Going On With Tharimmune Shares Wednesday?
October 30, 2024
Tharimmune, Inc. (NASDAQ:THAR) shares are moving higher on Wednesday after the company announced it received overall positive feedback from the European Medicines Agency (EMA) on its TH104 clinical... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 30, 2024
Via Benzinga
THAR Stock Earnings: Tharimmune Reported Results for Q2 2024
August 12, 2024
Tharimmune just reported results for the second quarter of 2024. 
Via InvestorPlace
Why Tharimmune (THAR) Shares Are Moving
May 22, 2024
Tharimmune shares are trading lower by 16.4% during Wednesday's session. The company announced a 1-for-15 reverse stock split. 
Via Benzinga
THAR Stock Earnings: Tharimmune Reported Results for Q4 2023
May 09, 2024
Tharimmune just reported results for the fourth quarter of 2023. 
Via InvestorPlace
Dow Surges Over 150 Points; Alphabet Posts Upbeat Results
October 30, 2024
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's After-Market Session
October 04, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 30, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 17, 2024
Via Benzinga
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 10, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 10, 2024
Via Benzinga
Why Tharimmune (THAR) Shares Are Getting Hammered
June 10, 2024
Tharimmune shares are trading lower by 30% during Monday's session. The company late Friday announced it had entered into an "at the market" offering agreement. 
Via Benzinga
Why Is Verastem (VSTM) Stock Down 62% Today?
May 24, 2024
Verastem stock is down on Friday with heavy trading of VSTM shares alongside its latest pancreatic cancer clinical trial safety data. 
Via InvestorPlace
Why Is Sensei Biotherapeutics (SNSE) Stock Down 40% Today?
May 24, 2024
Sensei Biotherapeutics stock is falling on Friday as SNSE investors are unimpressed by its latest clinical trial data. 
Via InvestorPlace
Why Is Tharimmune (THAR) Stock Moving Today?
May 24, 2024
Tharimmune stock is on the move Friday as investors prepare for a reverse split of THAR shares after markets close today. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 24, 2024
We're diving into the biggest pre-market stock movers that traders need to know about on Friday morning with all of the latest news! 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 22, 2024
Via Benzinga
Tharimmune's Oral 'Under The Cheek' Candidate At Par With FDA-Approved Injectable With Potential For Chronic Liver Disease
February 20, 2024
Tharimmune achieves success in Phase 1 trial for TH104, a buccal film with nalmefene. Encouraging safety profile and potential for liver-related conditions. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 20, 2024
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 25, 2024
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 24, 2024
Via Benzinga
Perspective Therapeutics And 3 Other Stocks Under $1 Insiders Are Buying
December 19, 2023
The Dow Jones index closed slightly higher on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
December 08, 2023
Shares of Hello Group Inc. (NASDAQ: MOMO) jumped in pre-market trading after reporting results for the third quarter. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 07, 2023
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 04, 2023
Via Benzinga
Crude Oil Surges 2%; Tharimmune Shares Plummet
November 28, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Tuesday. The Dow traded up 0.27% to 35,429.20 while the NASDAQ rose 0.12% to 14,258.32. The... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 28, 2023
Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering. 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap